Anthill Ventures, a leading global venture capital firm and speed-scaling ecosystem, has announced the launch of a new cohort for its Lumos Health programme.
The Lumos Health programme is designed for startups with disruptive solutions and health technologies. With a focus on high-impact verticals such as oncology, fertility, maternal health, genomics, cutting edge diagnostic, digital health and longevity.
The programme will provide startups with access to Anthill's global network of investors, mentors, and industry experts, as well as a range of resources designed to help startups grow their businesses. The programme has also established new partnerships with the Mazumdar Shaw Medical Foundation, Kauvery Hospitals, DERBI Foundation and Makers Nest, providing startups with access to a total of 51 hospitals across the country through partners.
Startups will be provided with enhanced opportunities, including access to state-of-the-art wet lab facilities, invaluable clinical validation support, and comprehensive evaluation of their market-ready solutions. The programme is also supported by partner HealthCare Global (HCG), India’s largest cancer care provider.
The Lumos Health program will also support startups on regulatory processes, funding advice and market access. Startups will also get access to the larger network and up to $1 million worth of infrastructure support. Lumos Health has evaluated over 500 startups and 11 startups successfully qualified for their scaling programmes.
